131 related articles for article (PubMed ID: 7884581)
1. Angiotensin II antagonists DuP 753 and TCV 116.
Brunner HR; Delacrétaz E; Nussberger J; Burnier M; Waeber B
J Hypertens Suppl; 1994 Nov; 12(9):S29-34. PubMed ID: 7884581
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II antagonists.
Brunner HR; Nussberger J; Burnier M; Waeber B
Clin Exp Hypertens; 1993 Nov; 15(6):1221-38. PubMed ID: 8268887
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II blockade compared with other pharmacological methods of inhibiting the renin-angiotensin system.
Brunner HR; Nussberger J; Waeber B
J Hypertens Suppl; 1993 Apr; 11(3):S53-8. PubMed ID: 8315521
[TBL] [Abstract][Full Text] [Related]
4. DuP 532, an angiotensin II receptor antagonist: first administration and comparison with losartan.
Goldberg MR; Lo MW; Christ DD; Chiou R; Furtek CI; Amit O; Carides A; Biollaz J; Piguet V; Nussberger J; Brunner HR
Clin Pharmacol Ther; 1997 Jan; 61(1):59-69. PubMed ID: 9024174
[TBL] [Abstract][Full Text] [Related]
5. Clinical experience with angiotensin II receptor antagonists.
Lee RJ; Brunner HR
J Hum Hypertens; 1993 Aug; 7 Suppl 2():S33-6. PubMed ID: 8230087
[TBL] [Abstract][Full Text] [Related]
6. Clinical experience with angiotensin II receptor antagonists.
Brunner HR; Christen Y; Munafo A; Lee RJ; Waeber B; Nussberger J
Am J Hypertens; 1992 Dec; 5(12 Pt 2):243S-246S. PubMed ID: 1290619
[TBL] [Abstract][Full Text] [Related]
7. Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review.
Dahlöf B
J Hum Hypertens; 1995 Nov; 9 Suppl 5():S37-44. PubMed ID: 8583480
[TBL] [Abstract][Full Text] [Related]
8. The advantages of angiotensin II antagonism.
Burnier M; Waeber B; Brunner HR
J Hypertens Suppl; 1994 Jul; 12(2):S7-15. PubMed ID: 7965267
[TBL] [Abstract][Full Text] [Related]
9. Sympathetic nerve activity in conscious renal hypertensive rats treated with an angiotensin converting enzyme inhibitor or an angiotensin II antagonist.
Niederberger M; Aubert JF; Nussberger J; Brunner HR; Waeber B
J Hypertens; 1995 Apr; 13(4):439-45. PubMed ID: 7629405
[TBL] [Abstract][Full Text] [Related]
10. Oral administration of DuP 753, a specific angiotensin II receptor antagonist, to normal male volunteers. Inhibition of pressor response to exogenous angiotensin I and II.
Christen Y; Waeber B; Nussberger J; Porchet M; Borland RM; Lee RJ; Maggon K; Shum L; Timmermans PB; Brunner HR
Circulation; 1991 Apr; 83(4):1333-42. PubMed ID: 2013151
[TBL] [Abstract][Full Text] [Related]
11. Effects of losartan on the renin-angiotensin-aldosterone axis in essential hypertension.
Bauer IH; Reams GP; Wu Z; Lau-Sieckman A
J Hum Hypertens; 1995 Apr; 9(4):237-43. PubMed ID: 7595905
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II receptor antagonists versus angiotensin converting enzyme inhibitors: effects on renal function.
Jover B; Mimran A
J Hypertens Suppl; 1994 Nov; 12(9):S3-9. PubMed ID: 7884582
[TBL] [Abstract][Full Text] [Related]
13. Nonpeptide angiotensin II receptor antagonists. IX. Antihypertensive activity in rats of DuP 753, an orally active antihypertensive agent.
Wong PC; Price WA; Chiu AT; Duncia JV; Carini DJ; Wexler RR; Johnson AL; Timmermans PB
J Pharmacol Exp Ther; 1990 Feb; 252(2):726-32. PubMed ID: 2179532
[TBL] [Abstract][Full Text] [Related]
14. Role of the renin-angiotensin system in hypertension in the elderly.
Nagano M; Higaki J; Mikami H; Ogihara T
Blood Press Suppl; 1994; 5():130-3. PubMed ID: 7889195
[TBL] [Abstract][Full Text] [Related]
15. [Non-peptide antagonists to angiotensin II receptors. A review].
Schambye HT; Hjorth SA; Schwartz TW
Ugeskr Laeger; 1993 Nov; 155(44):3558-62. PubMed ID: 8236577
[TBL] [Abstract][Full Text] [Related]
16. The future role of losartan.
Hansson L
J Hum Hypertens; 1995 Nov; 9 Suppl 5():S55-8. PubMed ID: 8583483
[TBL] [Abstract][Full Text] [Related]
17. Acute and chronic effects of losartan (DuP 753) on blood pressure and vascular reactivity in normotensive rats.
Soltis EE; Jewell AL; Dwoskin LP; Cassis LA
Clin Exp Hypertens; 1993 Jan; 15(1):171-84. PubMed ID: 8467311
[TBL] [Abstract][Full Text] [Related]
18. Effects of the angiotensin II receptor antagonist, TCV-116, on blood pressure and the renin-angiotensin system in healthy subjects.
Ogihara T; Nagano M; Mikami H; Higaki J; Kohara K; Azuma J; Aoki T; Hamanaka Y
Clin Ther; 1994; 16(1):74-86. PubMed ID: 8205603
[TBL] [Abstract][Full Text] [Related]
19. New perspectives in angiotensin system control.
Timmermans PB; Wong PC; Chiu AT; Herblin WF; Smith RD
J Hum Hypertens; 1993 Aug; 7 Suppl 2():S19-31. PubMed ID: 8230085
[TBL] [Abstract][Full Text] [Related]
20. Effects of the angiotensin II receptor antagonist Losartan (DuP 753/MK 954) on arterial blood pressure, heart rate, plasma concentrations of angiotensin II and renin and the pressor response to infused angiotensin II in the salt-deplete dog.
MacFadyen RJ; Tree M; Lever AF; Reid JL
Clin Sci (Lond); 1992 Nov; 83(5):549-56. PubMed ID: 1335390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
